G. E. Marlin
-
- Inhalation and Respiratory Drug Delivery 15
- Respiratory and Cough-Related Research 11
- Chronic Obstructive Pulmonary Disease (COPD) Research 7
- Cystic Fibrosis Research Advances 5
- Molecular Medicine top 10%
- Physiology top 10%
- Asthma and respiratory diseases 14
- Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy 6
-
- Pneumonia and Respiratory Infections 9
-
- Pharmacological Effects and Assays 6
- Co-authors
- Norbert BerendA J WoolcockAnn J. WoolcockKeith R. BurgessC M KayeCR KumanaD Morison SmithChristine Jenkins
- Partner nations
- AustraliaUnited StatesSweden
In The Last Decade
G. E. Marlin
36 papers receiving 559 citations
Peers
Comparison fields: 5 of 84
- Pulmonary and Respiratory Medicine 411
- Molecular Medicine 51
- Physiology 206
- Pharmacology 125
- Applied Microbiology and Biotechnology 10
Countries citing papers authored by G. E. Marlin
This map shows the geographic impact of G. E. Marlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. E. Marlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. E. Marlin more than expected).
Fields of papers citing papers by G. E. Marlin
This network shows the impact of papers produced by G. E. Marlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. E. Marlin. The network helps show where G. E. Marlin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside G. E. Marlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 8 | |
| 2 | 1988 | 6 | |
| 3 | 1985 | 7 | |
| 4 | 1985 | 13 | |
| 5 | 1984 | 21 | |
| 6 | 1983 | 3 | |
| 7 | 1983 | 20 | |
| 8 | 1983 | 19 | |
| 9 | 1981 | 2 | |
| 10 | 1981 | 18 | |
| 11 | 1980 | 16 | |
| 12 | 1980 | 16 | |
| 13 | 1980 | 1 | |
| 14 | Pharmacokinetics and tolerability of a single oral 600-mg dose of doxycycline. | 1979 | 7 |
| 15 | 1979 | 17 | |
| 16 | 1979 | 7 | |
| 17 | 1978 | 10 | |
| 18 | 1976 | 10 | |
| 19 | 1976 | 26 | |
| 20 | 1975 | 16 |
About G. E. Marlin
G. E. Marlin is a scholar working on Pulmonary and Respiratory Medicine, Molecular Medicine, Animal Science and Zoology, Physiology and Critical Care and Intensive Care Medicine, having authored 37 papers that have together received 651 indexed citations. Recurring topics across this work include Inhalation and Respiratory Drug Delivery (15 papers), Asthma and respiratory diseases (14 papers), Respiratory and Cough-Related Research (11 papers), Pneumonia and Respiratory Infections (9 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers), Pharmacological Effects and Assays (6 papers) and Cystic Fibrosis Research Advances (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (411 citations), Molecular Medicine (51 citations), Physiology (206 citations), Pharmacology (125 citations) and Applied Microbiology and Biotechnology (10 citations). G. E. Marlin has collaborated with scholars based in Australia, United States and Sweden. Frequent co-authors include Norbert Berend, A J Woolcock, Ann J. Woolcock, Keith R. Burgess, C M Kaye, CR Kumana, D Morison Smith, Christine Jenkins, James R. Wright and William M. Thurlbeck. Their work appears in journals such as Thorax, CHEST Journal, Current Medical Research and Opinion, The Medical Journal of Australia and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.